Baxter International (BAX) Stock Forecast & Price Target

$35.25
+0.08 (+0.23%)
(As of 05/17/2024 ET)

Baxter International Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 10 Analyst Ratings

Analysts' Consensus Price Target

$45.73
29.72% Upside
High Forecast$56.00
Average Forecast$45.73
Low Forecast$36.00
TypeCurrent Forecast
5/18/23 to 5/17/24
1 Month Ago
4/18/23 to 4/17/24
3 Months Ago
2/17/23 to 2/17/24
1 Year Ago
5/18/22 to 5/18/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
8 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
9 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$45.73$46.30$46.30$52.38
Predicted Upside29.72% Upside12.76% Upside14.80% Upside13.22% Upside
Get Baxter International Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

BAX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Baxter International Stock vs. The Competition

TypeBaxter InternationalMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.70
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside29.72% Upside697.04% Upside7.81% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/10/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$40.00+11.27%
4/3/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$41.00 ➝ $44.00+1.71%
3/5/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$42.00 ➝ $45.00+2.93%
2/12/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$52.00 ➝ $54.00+35.71%
2/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$38.00 ➝ $44.00+10.58%
2/6/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$40.00 ➝ $36.00-8.28%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$45.00 ➝ $39.00+6.70%
10/24/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$35.00 ➝ $50.00+52.72%
7/31/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$53.00 ➝ $51.00+8.49%
7/28/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$46.00 ➝ $44.00-2.11%
7/12/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$54.00 ➝ $56.00+21.66%
5/30/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingAssumes

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:21 PM ET.

BAX Price Target - Frequently Asked Questions

What is Baxter International's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Baxter International stock is Hold based on the current 8 hold ratings and 2 buy ratings for BAX. The average twelve-month price prediction for Baxter International is $45.73 with a high price target of $56.00 and a low price target of $36.00. Learn more on BAX's analyst rating history.

Do Wall Street analysts like Baxter International more than its competitors?

Analysts like Baxter International less than other Medical companies. The consensus rating for Baxter International is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how BAX compares to other companies.

Is Baxter International being downgraded by Wall Street analysts?

Over the previous 90 days, Baxter International's stock had 1 downgrade by analysts.

Does Baxter International's stock price have much upside?

According to analysts, Baxter International's stock has a predicted upside of 12.70% based on their 12-month stock forecasts.

What analysts cover Baxter International?

Baxter International has been rated by Bank of America, Citigroup, and TD Cowen in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:BAX) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners